Lek’s scientists receive the Prometheus in Science Award for Communication Excellency and the title Star of the Slovenian Science Festival
- Researchers Vesna Stergar, PhD, and Dušan Teslić, PhD, received the Prometheus in Science Award for exceptional achievements in communicating science with various audiences. The special title of the Star of the Slovenian Science Festival was received by Zlatko Pflaum, PhD, for innovative workshop with thought experiments.
- The Slovenian Scientific Foundation, a national non-profit institution for accelerating and promoting science in Slovenia, has been presenting the awards since 2003.
- By receiving the awards, Lek demonstrates its excellence in communicating science and raising awareness of science and innovation as important elements of the economic and social development.
Vesna Stergar, PhD, from the Biopharmaceuticals Mengeš, and Dušan Teslić, PhD, from the Development Center Slovenia, have received this year's Prometheus in Science Award for Communication Excellency. They received the award for their exceptional performance in promoting science and searching for new solutions and connections in their departments, company-wide, and in the country’s broader research environment. Zlatko Pflaum, PhD, from Biopharmaceuticals Mengeš, received a special honorary title of the Star of the Slovenian Science Festival, for the design and implementation of an innovative workshop for children, where he demonstrated the importance of innovative thinking with thought experiments. Additionally, Lek received the award for an excellent partnership in organization of the 24th Slovenian Science Festival.
This year, The Slovenian Scientific Foundation presented 13 Prometheus in Science Awards for Communication Excellency to individuals or groups demonstrating significant achievements in communicating science with various audiences. Prometheus in Science Award is the highest and the only prize presented to researchers, artists, teachers and journalists, who use their work to communicate science with various audiences and place special emphasis on promoting science in general public. The Prometheus in Science Award for lifetime achievements was given to the longtime journalist of the daily Delo Dragica Bošnjak, who devoted most of her journalistic career to writing about the achievements of Slovenian researchers and innovations in science, especially in the field of medicine.
For Lek’s associates, this is already the second Prometheus in Science Award received. In 2016, they received the award for their strategic and successful communication of the Regional BioCamp 2015 (link). This award reflects the company’s devotion to development and scientific advancement in relation to broader public and builds meaningful connections between academics and industry.
So far, Vesna Stergar, PhD, and Dušan Teslić, PhD, have received several national and international awards. The Prometheus in Science Award demonstrates their paramount contribution to communicating science to the wider audience. The researchers have distinguished themselves by creating innovative work environment, developing and maintaining continuous long-term cooperation with different partners, and co-creating the work program. Both researchers spend a lot of time and energy to cooperate with faculties and institutes to strengthen the bonds between industry and science. “To be successful in science, we must work together towards an environment that encourages creativity and innovative thinking. We are aware of the fact that it is important for the wider audience to recognize the meaning of science in our lives and to bring science closer to them – in an understandable way. By doing so, we also create new talents and ambassadors, who will define our future success. This award proves that we are on the right track. We will continue to communicate the development of science and innovation as our core value and create new connections with general public,” said Vesna Stergar, PhD, and Dušan Teslić, PhD, upon receiving the award.
Every year, the Slovenian Science Foundation chooses also the most interesting and innovative communicator of science at the Slovenian Science Festival, which has been organized since 1994. The star of the Slovenian Science Festival for 2018 is Zlatko Pflaum, PhD, who prepared a workshop with his colleague Janko Ignjatović, where they presented innovation as a way of thinking, working and creating. The presentation took place in the form of a workshop with several thought experiments. With their help, the participants understood better what they should focus on when turning innovation theory into practice.
Novartis is the leading provider of medicines in Slovenia, where Lek, Novartis Pharma Services and Sandoz, operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role in Novartis' organizational structure, especially in the Novartis Technical Operations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Novartis invested in Slovenia more than EUR 2 billion since 2003. More than half of this investment has been devoted to development, and the rest to modernize and expand our production capacities.
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1,000 molecules, covering all major therapeutic areas, accounted for 2017 sales of USD 10.1 billion. In 2017, our products reached well over 500 million patients. Sandoz is headquartered in Holzkirchen, in Germany's Greater Munich area.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32